Literature DB >> 20852043

Increased C-reactive protein expression exacerbates left ventricular dysfunction and remodeling after myocardial infarction.

Toshiyuki Takahashi1, Toshihisa Anzai, Hidehiro Kaneko, Yoshinori Mano, Atsushi Anzai, Toshiyuki Nagai, Takashi Kohno, Yuichiro Maekawa, Tsutomu Yoshikawa, Keiichi Fukuda, Satoshi Ogawa.   

Abstract

We previously reported serum C-reactive protein (CRP) elevation after acute myocardial infarction (MI) to be associated with adverse outcomes including cardiac rupture, left ventricular (LV) remodeling, and cardiac death. Experimental studies have indicated that CRP per se has various biological actions including proinflammatory and proapoptotic effects, suggesting a pathogenic role of CRP in the post-MI remodeling process. We tested the hypothesis that increased CRP expression would exacerbate adverse LV remodeling after MI via deleterious effects of CRP. Transgenic mice with human CRP expression (CRP-Tg) and their transgene-negative littermates (control) underwent left coronary artery ligation. There was no apparent difference in phenotypic features between CRP-Tg and control mice before MI. Although mortality and infarct size were similar in the two groups, CRP-Tg mice showed more LV dilation and worse LV function with more prominent cardiomyocyte hypertrophy and fibrosis in the noninfarcted regions after MI than controls. Histological evaluation conducted 1 wk post-MI revealed a higher rate of apoptosis and more macrophage infiltration in the border zones of infarcted hearts from CRP-Tg mice in relation to increased monocyte chemotactic protein (MCP)-1 expression and matrix metalloproteinase (MMP)-9 activity. Increased CRP expression exacerbates LV dysfunction and promotes adverse LV remodeling after MI in mice. The deleterious effect of CRP on post-MI LV remodeling may be associated with increased apoptotic rates, macrophage infiltration, MCP-1 expression, and MMP-9 activity in the border zone.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20852043     DOI: 10.1152/ajpheart.00001.2010

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  14 in total

1.  C-reactive protein promotes diabetic kidney disease in a mouse model of type 1 diabetes.

Authors:  F Liu; H Y Chen; X R Huang; A C K Chung; L Zhou; P Fu; A J Szalai; H Y Lan
Journal:  Diabetologia       Date:  2011-07-09       Impact factor: 10.122

Review 2.  Inflammatory activation: cardiac, renal, and cardio-renal interactions in patients with the cardiorenal syndrome.

Authors:  Paolo C Colombo; Anjali Ganda; Jeffrey Lin; Duygu Onat; Ante Harxhi; Julia E Iyasere; Nir Uriel; Gad Cotter
Journal:  Heart Fail Rev       Date:  2012-03       Impact factor: 4.214

Review 3.  Insight into the Role of the PI3K/Akt Pathway in Ischemic Injury and Post-Infarct Left Ventricular Remodeling in Normal and Diabetic Heart.

Authors:  Bartosz Walkowski; Marcin Kleibert; Miłosz Majka; Małgorzata Wojciechowska
Journal:  Cells       Date:  2022-05-05       Impact factor: 7.666

4.  Association Between Inflammatory Markers and Myocardial Fibrosis.

Authors:  Mateus D Marques; Victor Nauffal; Bharath Ambale-Venkatesh; Henrique D Vasconcellos; Colin Wu; Hossein Bahrami; Russell P Tracy; Mary Cushman; David A Bluemke; João A C Lima
Journal:  Hypertension       Date:  2018-10       Impact factor: 10.190

Review 5.  Matrix metalloproteinase (MMP)-9: a proximal biomarker for cardiac remodeling and a distal biomarker for inflammation.

Authors:  Ganesh V Halade; Yu-Fang Jin; Merry L Lindsey
Journal:  Pharmacol Ther       Date:  2013-04-03       Impact factor: 12.310

6.  Value of C-reactive protein in predicting left ventricular remodelling in patients with a first ST-segment elevation myocardial infarction.

Authors:  Iwona Swiatkiewicz; Marek Kozinski; Przemyslaw Magielski; Tomasz Fabiszak; Adam Sukiennik; Eliano Pio Navarese; Grazyna Odrowaz-Sypniewska; Jacek Kubica
Journal:  Mediators Inflamm       Date:  2012-09-02       Impact factor: 4.711

7.  Usefulness of C-reactive protein as a marker of early post-infarct left ventricular systolic dysfunction.

Authors:  Iwona Swiatkiewicz; Marek Kozinski; Przemyslaw Magielski; Joanna Gierach; Tomasz Fabiszak; Aldona Kubica; Adam Sukiennik; Eliano Pio Navarese; Grazyna Odrowaz-Sypniewska; Jacek Kubica
Journal:  Inflamm Res       Date:  2012-03-24       Impact factor: 4.575

8.  Prognostic value of pentraxin-3 level in patients with STEMI and its relationship with heart failure and markers of oxidative stress.

Authors:  Marie Tomandlova; Jiri Jarkovsky; Josef Tomandl; Lenka Kubkova; Petr Kala; Simona Littnerova; Jana Gottwaldova; Petr Kubena; Eva Ganovska; Martin Poloczek; Jindrich Spinar; Christian Mueller; Alexandre Mebazaa; Monika Pavkova Goldbergova; Jiri Parenica
Journal:  Dis Markers       Date:  2015-04-01       Impact factor: 3.434

9.  Effects of heme oxygenase-1 upregulation on blood pressure and cardiac function in an animal model of hypertensive myocardial infarction.

Authors:  Tian-Meng Chen; Jian Li; Lin Liu; Li Fan; Xiao-Ying Li; Yu-Tang Wang; Nader G Abraham; Jian Cao
Journal:  Int J Mol Sci       Date:  2013-01-28       Impact factor: 5.923

Review 10.  Recognition functions of pentameric C-reactive protein in cardiovascular disease.

Authors:  Alok Agrawal; Toh B Gang; Antonio E Rusiñol
Journal:  Mediators Inflamm       Date:  2014-05-19       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.